Categories Earnings, Health Care
Earnings Summary: Highlights of IDEXX Laboratories’ Q3 2023 earnings
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, has reported financial results for the third quarter of 2023.
- The company reported revenues of $916 million for the third quarter of 2023, an increase of 9%; organic revenue growth was 8%
- Among the business divisions, Companion Animal Group revenue grew 9% and Water revenue rose 9%; CAG Diagnostics revenue was up 10%
- Third-quarter earnings per share were $2.53, which is up 18% on a reported basis and 16% on a comparable basis
- Gross profits increased by 8% both as reported and on a comparable basis, while gross margin decreased by 30 basis points to 59.9%
- Operating margin was 30.1% in the September quarter, higher than the prior year by 100 basis points
- The company expects full-year revenues to grow in the range of 7.9%-8.4% as reported and 8.3%-8.8% organically
- Full-year reported operating margin is expected to be in the range of 29.6% to 29.8%
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent
Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1
Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three
After a positive year, what’s in the cards for Electronic Arts (EA) in FY25
Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter. The stock declined following the announcement as earnings
